Rockford woman is 1st in Wisconsin to receive newly-approved FDA ALS treatment

-
1:14
Milwaukee police, fire respond to major crash near 35th and Vliet
-
1:30
11-year-old shot, killed near 68th and Silver Spring
-
1:46
CBS 58’s Hometown Athlete: Milwaukee native Nelly Gleason up...
-
2:23
Executive order from Gov. Evers clears up COVID-19 vaccine confusion
-
0:57
Brewers sober tailgate event helps to end stigma on addiction...
-
2:55
‘I was feeling panicked’: Elkhorn administrator falsely linked...
-
1:38
International concourse to reopen at Mitchell International Airport...
-
6:08
Mason and Molly Crosby attend Madison event raising money for...
-
1:13
Operator of The Hop honored for protecting woman and her service...
-
0:42
Milwaukee County celebrates National Voter Registration Day
-
2:07
1 person dead after being struck by police car near 20th and...
-
2:21
Wauwatosa Christkindlmarkt holiday market canceled for 2025...
ROCKFORD, Ill. (CBS 58) -- A Rockford, Illinois woman is the first in Wisconsin to receive a new FDA-approved treatment for ALS, or Lou Gehrig's disease.
Michelle Francis was first diagnosed in 2019 with what's called the SOD1 mutation.
The disease has run in her family for seven generations, affecting 65 members and counting.
In April, UW Health in Madison offered a glimmer of hope -- a monthly treatment involved removing spinal fluid with a needle and replacing it with a new drug.
Now, nearly eight appointments later, Francis says she has hope for the first time.
"It will be here forever so we definitely have to have something to once you develop, there's some hope and I’m thinking this is gonna be it," said Francis.
Francis says she hopes others with ALS will hear her story, be inspired, and most importantly, not give up.